GlassScriptPhysician profile
Gerald R Fortuna
NPI 1447479829
$143,044.31
in general payments reported to CMS, 2019-2025
28 companies · $1,152 in 2025
The $1,152 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,898 · 2020: $25K · 2021: $62K · 2022: $34K · 2023: $13K · 2024: $6,148 · 2025: $1,152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Food and Beverage: $6,375 · Travel and Lodging: $1,929 · Education: $620.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,500.00 |
| Food and Beverage | $6,375.41 |
| Travel and Lodging | $1,928.57 |
| Education | $620.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $133,903.38 | 2019-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Endologix LLC | $2,276.12 | 2022-2025 | Ovation Ix Iliac Stent Graft, Afx2 Bifurcated Endograft System, Alto Abdominal Stent Graft System |
| Cook Medical LLC | $1,264.52 | 2019-2025 | Cook, Zilver Ptx |
| Prytime Medical Devices, INC. | $1,055.79 | 2019 | |
| W. L. Gore & Associates, INC. | $796.28 | 2019-2022 | |
| Medtronic, INC. | $543.87 | 2021-2025 | Abre, Ligasure, Ellipsys Vascular Access System |
| Silk Road Medical, INC. | $518.77 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Cardiovascular Systems INC. | $407.14 | 2019-2022 | |
| Medtronic Vascular, INC. | $321.24 | 2019 | |
| Shockwave Medical, INC | $304.10 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Lemaitre Vascular, INC. | $278.10 | 2020-2025 | Artegraft Vascular Graft |
| Organogenesis INC. | $184.68 | 2024-2025 | Affinity, Via Matrix, Puraply Wound Matrix |
| Philips North America LLC | $167.57 | 2024-2025 | (Dd3) Venous Stent Und, IV Other |
| Bolton Medical INC | $148.18 | 2022 | |
| Penumbra, INC. | $138.83 | 2020 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $122.83 | 2019 | |
| Cardiva Medical, INC. | $89.65 | 2022-2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Boston Scientific Corporation | $84.65 | 2022-2024 | Ranger |
| Kerecis Limited | $84.29 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Getinge USA Sales, LLC | $81.00 | 2022 | |
| Surmodics, INC. | $79.25 | 2022-2024 | Pounce Thrombectomy, Pounce Venous Thrombectomy System, Sublime Microcatheter, 018, 200cm, Straight |
| Stryker Corporation | $41.33 | 2025 | Ct Thrombectomy System Kit |
| Angiodynamics, INC. | $40.17 | 2021-2022 | |
| Bard Peripheral Vascular, INC. | $35.79 | 2023 | Venclose Maven Catheter |
| Integra Lifesciences Corporation | $28.53 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Covidien LP | $20.55 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $14.00 | 2022 | |
| Janssen Pharmaceuticals, INC | $13.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Fortuna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.